References
- Raghavan, D., Shipley, W, U., Garnick, M. B., Russell, P. J. and Richie, J. P. : Biology and management of bladder cancer. N. Engl. J. Med. 322, 1129 (1990). https://doi.org/10.1056/NEJM199004193221607
- Loening, S., Narayana, A., Yoder, L., Slymen, D., Weinstein, S., Penick, G. and Culp, D. : Factors influencing the recurrence rate of bladder cancer. J. Urol. 123, 29 (1980).
- Murphy, W. M., Soloway, M. S., Jukkola, A. F., Crabtree, W. N. and Ford, K. S. : Urinary cytology and bladder cancer. Cancer 53, 1555 (1984). https://doi.org/10.1002/1097-0142(19840401)53:7<1555::AID-CNCR2820530723>3.0.CO;2-G
- Rosenberg, B. : Fundamental studies with cisplatin. Cancer 55, 2303 (1985). https://doi.org/10.1002/1097-0142(19850515)55:10<2303::AID-CNCR2820551002>3.0.CO;2-L
- Ali, B. H. and Al Moundhri, M. S. : Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds : A review of some recent research. Food Chem. Toxicol. 44, 1173 (2006). https://doi.org/10.1016/j.fct.2006.01.013
- Lippert, B. : Impact of Cisplatin on the recent development of Pt coordination chemistry: a case study. Coord. Chem. Rev. 182, 263 (1999). https://doi.org/10.1016/S0010-8545(98)00192-1
- Chirino, Y. I., Hernandez-Pando, R. and Pedraza-Chaveri, J. : Peroxynitrite de composition catalyst ameliorates renal damage and protein nitration in cisplatin-induced nephrotoxicity in rats. BMC Pharmacol. 4, 20 (2004). https://doi.org/10.1186/1471-2210-4-20
- Go, R. S. and Adjei, A. A. : Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. J. Clin. Oncol. 17, 409 (1999).
- Senff-Ribeiro, A., Echevarria, A., Silva, E. F., Veigab, S. S. and Oliveiraa, M. B. M. : Antimelanoma activity of 1,3,4-thiadiazolium mesoionics: a structure-activity relationship study. Anticancer Drugs 15, 269 (2004). https://doi.org/10.1097/00001813-200403000-00012
- Oleson, J. J., Sloboda, A., Troy, W. P., Halliday, S. L., Landes, M. J., Angier, R. B., Semb, J., Cyr, K. and Williams, J. H. : The carcinostatic activity of some 2-amino-1,3,4-thiadiazoles. J. Am. Chem. Soc. 77, 6713 (1955).
- Foroumadi, A., Soltani, F., Moallemzadeh-Haghighi, H. and Shafiee, A. : Synthesis, in vitro-antimycobacterial activity and cytotoxicity of some alkyl a-(5-aryl-1,3,4-thiadiazole-2-ylthio) acetates. Arch. Pharm. 338, 112 (2005). https://doi.org/10.1002/ardp.200400926
- Bhattacharya, P., Leonard, J. T. and Roy, K. : Exploring QSAR of thiazole and thiadiazole derivatives as potent and selective human adenosine A3 receptor antagonists using FA and GFA techniques. Bio. Med. Chem. 13, 1159 (2005). https://doi.org/10.1016/j.bmc.2004.11.022
- Jung, K. Y., Kim, S. K., Gao, Z. G., Gross, A. S., Melman, N., Jacobson, K. A. and Kim, Y. C. : Structure activity relationships of thiazole and thiadiazole derivatives as potent and selective human adenosine A3 receptor antagonists. Bio. Med. Chem. 12, 613 (2004). https://doi.org/10.1016/j.bmc.2003.10.041
- Fontanini, G., Lucchi, M., Vignati, S., Mussi, A., Ciardiello, F., De Laurentis, M., De Placido, S., Basolo, F., Angeletti, C. A. and Bevilacqua, G. : Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study. J. Natl. Cancer Inst. 89, 881 (1997). https://doi.org/10.1093/jnci/89.12.881
- Kawaguchi, T., Yamamoto, S., Kudoh, S., Goto, K., Wakasa, K. and Sakurai, M. : Tumor angiogenesis as a major prognostic factor in stage I lung adenocarcinoma. Anticancer Res. 17, 3743 (1997).
- Soung, M. K., Kil, M. J. and Sung, N. D. : Structural characteristic that influence on the insecticidal activity of 2-(noctyl) pseudothiourea analogues against the Diamondback moth (Plutella xylostella. L.) Bull. Kor. Chem. Soc. 30, 2749 (2009). https://doi.org/10.5012/bkcs.2009.30.11.2749
- Soung, M. K., Lee, Y. J. and Sung, N. D. : 3D-QSARs of herbicidal 2-N-phenylisoindolin-1-one analogues as a new class of potent inhibitors of protox. Bull. Kor. Chem. Soc. 30, 613 (2009). https://doi.org/10.5012/bkcs.2009.30.3.613
- Soung, M. K., Myung, P. K. and Sung, N. D. : 3D-QSAR analysis on the inhibitory activity of [(2-phenylindol-3-yl)- methylene]propanedinitrile analogues against breast cancer cell and the ligand design of active molecules. J. Kor. Soc. Appl. Biol. Chem. 52, 28 (2009). https://doi.org/10.3839/jksabc.2009.005
- Kim, S. J., Myung, P. K. and Sung, N. D. : CoMFA on the melanogenesis inhibitory activity of alkyl-3,4-dihydroxybenzoate, N-alkyl-3,4-dihydroxybenzamide analogues, and prediction of higher active molecules. Arch. Pharm. Res. 31, 1540-1546 (2008). https://doi.org/10.1007/s12272-001-2148-4
- Akamatsu M. : Current state and perspectivies of 3D-QSAR. Curr. Topics Med. Chem. 2, 1381 (2002). https://doi.org/10.2174/1568026023392887
- Cramer, R. III, Patterson, D. E. and Bunce, J. D. : Comparative molecular field analysis (CoMFA) 1. Effect of shape on the binding of steroid to carrier proteins. J. Am. Chem. Soc. 110, 5959 (1988). https://doi.org/10.1021/ja00226a005
- Matysiak, J. and Opolski, A. : Synthesis and antiproliferative activity of N-substituted 2-amino-5-(2,4-dihydroxyphenyl)- 1,3,4-thiadiazoles. Bio. Med. Chem. 14, 4483 (2006). https://doi.org/10.1016/j.bmc.2006.02.027
- Reddy, M. R. and Parrill, A. L. : Overview of rational drug design. In Rational Drug, (ed. Eddy, M. R. and Parrill). Ch. 1. ACS Symposium Series. 719, p1 (1999).
- Klebe, G., Abraham, U. and Mietzner, T. : Molecular similarity indexes in a comparative analysis (comsia) of drug molecules to correlate and predict their biological-activity. J. Med. Chem. 37, 4130 (1994). https://doi.org/10.1021/jm00050a010
- Purushottamachar, P. and Kulkarni, V. M. : 3D-QSAR of Nmyristoyltransferase inhibiting antifungal agents by CoMFA and CoMSIA methods. Bio. Med. Chem. 11, 3486 (2003).